Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Non Operating Investment Income (2021 - 2022)

Historic Non Operating Investment Income for Immuneering (IMRX) over the last 2 years, with Q4 2022 value amounting to $112353.0.

  • Immuneering's Non Operating Investment Income rose 35385.92% to $112353.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $18889.0, marking a year-over-year change of. This contributed to the annual value of $18889.0 for FY2022, which is 13854.19% up from last year.
  • According to the latest figures from Q4 2022, Immuneering's Non Operating Investment Income is $112353.0, which was up 35385.92% from $39088.0 recorded in Q3 2022.
  • Over the past 5 years, Immuneering's Non Operating Investment Income peaked at $112353.0 during Q4 2022, and registered a low of -$118386.0 during Q1 2022.